Zdrowie i gospodarka · 04/08/2025
FDA Clears Path for Abbreviated New Drug Applications for Oxycodone and Acetaminophen
The FDA has determined that Roxicet, a combination of oxycodone and acetaminophen, was not withdrawn from sale due to safety or effectiveness concerns, paving the way for approval of generic versions of the medication.
Source: Federal Register — Food and Drug AdministrationOpen original release →